PRMT2: The Potential Drug Target and Biomarker for Histone-Arginine N-Methyltransferase

Target Name: PRMT2

NCBI ID: G3275

PRMT2

PRMT2: The Potential Drug Target and Biomarker for Histone-Arginine N-Methyltransferase

Histone-arginine N-methyltransferase (HAMT) is a protein that plays a crucial role in the regulation of gene expression and cell signaling. Mutations in the HAMT gene have been linked to various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. Therefore, identifying potential drug targets and biomarkers for HAMT has become an important research topic in the field of neuroscience.

PRMT2, a protein that belongs to the PRMT2 family, has been identified as a potential drug target and biomarker for HAMT. PRMT2 is a nuclear protein that is expressed in various tissues and cells, including brain, heart, and peripheral tissues. It plays a role in the regulation of gene expression by modifying the histone modifications on the nuclear chromatin.

The HAMT gene is a key regulator of gene expression, and its function is crucial for the development and maintenance of normal cellular processes. The HAMT gene encodes a protein that contains a N-terminal domain responsible for the N-glycosylation of histones, as well as a C-terminal domain that contains a conserved arginine N-methylation system (HMS). The HMS is a key regulatory site that plays a crucial role in the regulation of gene expression by modifying the histone modifications on the nuclear chromatin.

PRMT2 is a key regulator of the HMS, and its function in the regulation of gene expression is crucial for the development and maintenance of normal cellular processes. The HAMT gene is a key regulator of gene expression, and its function is crucial for the development and maintenance of normal cellular processes. The HAMT gene encodes a protein that contains a N-terminal domain responsible for the N-glycosylation of histones, as well as a C-terminal domain that contains a conserved arginine N-methylation system (HMS). The HMS is a key regulatory site that plays a crucial role in the regulation of gene expression by modifying the histone modifications on the nuclear chromatin.

Studies have shown that PRMT2 plays a role in the regulation of gene expression by modifying the HMS. It has been shown that PRMT2 can add a N-terminal glycosylation to the HMS, which can alter its stability and function. Additionally, studies have shown that PRMT2 can also remove a N-terminal glycosylation from the HMS, which can also alter its stability and function.

PRMT2 has also been shown to play a role in the regulation of cellular processes by modifying the histone modifications on the nuclear chromatin. It has been shown that PRMT2 can add a N-terminal glycosylation to the histone tails, which can alter their stability and function. Additionally, studies have shown that PRMT2 can also remove a N-terminal glycosylation from the histone tails, which can also alter their stability and function.

In conclusion, PRMT2 is a protein that plays a crucial role in the regulation of gene expression by modifying the HMS on the nuclear chromatin. Its function in the regulation of cellular processes by modifying the histone modifications on the nuclear chromatin makes it an attractive drug target and biomarker for the development of neurodegenerative diseases. Therefore, further research is needed to understand the full function of PRMT2 and its potential as a drug target and biomarker.

Protein Name: Protein Arginine Methyltransferase 2

Functions: Arginine methyltransferase that methylates the guanidino nitrogens of arginyl residues in proteins such as STAT3, FBL, histone H4. Acts as a coactivator (with NCOA2) of the androgen receptor (AR)-mediated transactivation. Acts as a coactivator (with estrogen) of estrogen receptor (ER)-mediated transactivation. Enhances PGR, PPARG, RARA-mediated transactivation. May inhibit NF-kappa-B transcription and promote apoptosis. Represses E2F1 transcriptional activity (in a RB1-dependent manner). May be involved in growth regulation

The "PRMT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRMT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets